Table 8 Predictors of stocking of ASAQ-ACT by PPMVs
Variables | Artesunate (ASAQ) yes n (%) | Amodiaquine in stock no n (%) | X2 (p-value) | OR (95% CI) |
|---|---|---|---|---|
Outlet type | ||||
 Urban (ref) | 1 (0.6) | 159 (99.4) |  |  |
 Rural | 8 (5.0) | 152 (95.0) | 5.60 (0.018) * | 8.37 (1.03–67.71) |
Training on malaria treatment in the last 12Â months | ||||
 Not received training (ref) | 2 (1.1) | 174 (98.9) |  |  |
 Received training | 7 (4.9) | 137 (95.1) | 4.02 (0.045) | 4.45 (0.91–21.74) |
PPMV knew ASAQ is the alternate anti-malarial recommended by the government for uncomplicated malaria | ||||
 Correct knowledge (ref) | 2 (22.2) | 7 (77.8) |  |  |
 Incorrect knowledge | 7 (2.3) | 304 (97.7) | 12.76 (0.001) * | 0.08 (0.01–0.46) |
Government agencies as source of information on government recommended anti-malarial medication | ||||
 No (ref) | 8 (2.5) | 307 (97.5) |  |  |
 Yes | 1 (20.0) | 4 (80.0) | 5.49 (0.019) * | 9.59 (0.96–95.78) |
PPMV knew the national recommended guideline for malaria diagnosis | ||||
 Incorrect knowledge (ref) | 8 (2.6) | 304 (97.4) |  |  |
 Correct knowledge | 1 (12.5) | 7 (87.5) | 2.82 (0.093) | 5.43 (0.60––49.47) |